NuScale Net Loss Widens to $168.1 Million as Revenue Plunges 84.5% Amid Transition; New Customer Deals Boost Liquidity

SEC Track
09 Nov 2024

Core Highlights: - Net loss increased by 36.0% to $168.1 million for the nine months ended September 30, 2024 compared to the prior year period - Gross margin decreased significantly from 17.1% to 33.4% year-over-year - Total revenue decreased by 84.5% due to the loss of the contract with CFPP LLC
Revenue Breakdown: - Revenue decreased due to loss of the CFPP LLC contract, as the Company transitions from a R&D company towards commercialization of its small modular reactor technology - During Q3 2024, the Company entered into a new revenue generating agreement structured as a fixed price contract with variable consideration, with amounts collected deferred as a customer deposit until performance obligations are achieved - Subsequent to September 30, 2024, the Company executed a revenue generating agreement with Fluor to provide engineering and design services for a VOYGRTM-6 Nuclear Power Generation project
Management Outlook: - R&D expenses decreased due to $6.0 million lower compensation costs from workforce reduction and $74.5 million lower professional fees including a $34.5 million CFPP LLC contract termination fee - G&A expenses increased due to $7.4 million higher strategic marketing expenses, partially offset by lower professional fees and cost controls - Sponsored cost share from DOE and other entities decreased due to loss of CFPP LLC contract - Change in fair value of warrant liabilities was an unfavorable $53.0 million due to an increase in the Company's warrant price
Operating Data: - Net cash used in operating activities improved to $82.2 million outflow for the nine months ended September 30, 2024 compared to $110.0 million in the prior year period - Net cash used in investing activities was $44.8 million for purchase of short-term investments - Net cash provided by financing activities was $118.4 million from utilization of ATM program - The current cash balance of $116.7 million combined with the ATM program is expected to provide sufficient funding for the next 12 months - Cash is expected to support operations for 4.7 quarters under the current loss run-rate
Operational Risks: - Contingencies related to ongoing litigation with purported members/option holders of NuScale LLC and shareholder class action lawsuits - Risks around failure to initiate commercial operation of Nuclear Power Module 1 resulting in potential repayment obligations to DOE - Risks related to the SEC's current request for information regarding employment, severance, and confidentiality agreements

Original Filing

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10